Events & Promotions
|
|
GMAT Club Daily Prep
Thank you for using the timer - this advanced tool can estimate your performance and suggest more practice questions. We have subscribed you to Daily Prep Questions via email.
Customized
for You
Track
Your Progress
Practice
Pays
Not interested in getting valuable practice questions and articles delivered to your email? No problem, unsubscribe here.
Nov 1811:00 AM PST
-12:00 PM PST
Join us in a live GMAT practice session and solve 30 challenging GMAT questions with other test takers in timed conditions, covering GMAT Quant, Data Sufficiency, Data Insights, Reading Comprehension, and Critical Reasoning questions.
Nov 2211:00 AM IST
-01:00 PM IST
Do RC/MSR passages scare you? e-GMAT is conducting a masterclass to help you learn – Learn effective reading strategies Tackle difficult RC & MSR with confidence Excel in timed test environment- Nov 23
11:00 AM IST
-01:00 PM IST
Attend this free GMAT Algebra Webinar and learn how to master the most challenging Inequalities and Absolute Value problems with ease. 
Nov 2510:00 AM EST
-11:00 AM EST
Prefer video-based learning? The Target Test Prep OnDemand course is a one-of-a-kind video masterclass featuring 400 hours of lecture-style teaching by Scott Woodbury-Stewart, founder of Target Test Prep and one of the most accomplished GMAT instructors.
09 Apr 2020, 05:08
Kudos
Bookmarks
A
Be sure to select an answer first to save it in the Error Log before revealing the correct answer (OA)!
Difficulty:
25%
(medium)
Question Stats:
78% (02:04) correct
22%
(02:16)
wrong
based on 462
sessions
History
Date
Time
Result
Not Attempted Yet
A director of the Rexx Pharmaceutical Company argued that the development costs for new vaccines that the health department has requested should be subsidized by the government, since the marketing of vaccines promised to be less profitable than the marketing of any other pharmaceutical product. In support of this claim the director argued that sales of vaccines are likely to be lower since each vaccine is administered to a patient only once, whereas medicines that combat diseases and chronic illnesses are administered many times to each patient.
Which one of the following, if true, most weakens the support offered by the company director for the claim concerning the marketing of vaccines?
(A) Vaccines are administered to many more people than are most other pharmaceutical products.
(B) Many of the diseases that vaccines are designed to prevent can be successfully treated by medicines.
(C) Pharmaceutical companies occasionally market products that are neither medicines nor vaccines.
(D) Pharmaceutical companies other than the Rexx Pharmaceutical Company produce vaccines.
(E) The cost of administering a vaccine is rarely borne by the pharmaceutical company that manufactures that vaccine.
Which one of the following, if true, most weakens the support offered by the company director for the claim concerning the marketing of vaccines?
(A) Vaccines are administered to many more people than are most other pharmaceutical products.
(B) Many of the diseases that vaccines are designed to prevent can be successfully treated by medicines.
(C) Pharmaceutical companies occasionally market products that are neither medicines nor vaccines.
(D) Pharmaceutical companies other than the Rexx Pharmaceutical Company produce vaccines.
(E) The cost of administering a vaccine is rarely borne by the pharmaceutical company that manufactures that vaccine.
14 Apr 2020, 07:57
Kudos
Bookmarks
A weakens the argument. More no of people means more vaccine that Pharmaceutical Company
14 Apr 2020, 10:25
Kudos
Bookmarks
A director of the Rexx Pharmaceutical Company argued that the development costs for new vaccines that the health department has requested should be subsidized by the government, since the marketing of vaccines promised to be less profitable than the marketing of any other pharmaceutical product. In support of this claim the director argued that sales of vaccines are likely to be lower since each vaccine is administered to a patient only once, whereas medicines that combat diseases and chronic illnesses are administered many times to each patient.
Which one of the following, if true, most weakens the support offered by the company director for the claim concerning the marketing of vaccines?
(A) Vaccines are administered to many more people than are most other pharmaceutical products.
(B) Many of the diseases that vaccines are designed to prevent can be successfully treated by medicines.
(C) Pharmaceutical companies occasionally market products that are neither medicines nor vaccines.
(D) Pharmaceutical companies other than the Rexx Pharmaceutical Company produce vaccines.
(E) The cost of administering a vaccine is rarely borne by the pharmaceutical company that manufactures that vaccine
sales of vaccines are likely to be lower since each vaccine is administered to a patient only once, whereas medicines that combat diseases and chronic illnesses are administered many times to each patient.
The answer is "A".
Medicine is only for patients but vaccines can be for normal healthy people, who want the vaccine in case they may get a disease.
Which one of the following, if true, most weakens the support offered by the company director for the claim concerning the marketing of vaccines?
(A) Vaccines are administered to many more people than are most other pharmaceutical products.
(B) Many of the diseases that vaccines are designed to prevent can be successfully treated by medicines.
(C) Pharmaceutical companies occasionally market products that are neither medicines nor vaccines.
(D) Pharmaceutical companies other than the Rexx Pharmaceutical Company produce vaccines.
(E) The cost of administering a vaccine is rarely borne by the pharmaceutical company that manufactures that vaccine
sales of vaccines are likely to be lower since each vaccine is administered to a patient only once, whereas medicines that combat diseases and chronic illnesses are administered many times to each patient.
The answer is "A".
Medicine is only for patients but vaccines can be for normal healthy people, who want the vaccine in case they may get a disease.
